Business
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
(TheNewswire) Calgary, Alberta, Canada, June 11, 2024 – TheNewswire – ...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, Alberta, Canada, June 11, 2024 –\n \n \n TheNewswire –\n \n \n Voyageur Pharmaceuticals Ltd\n \n \n . (TSX.V: VM) (USA: VYYRF) (\"Voyageur\" or the\n\"Company\") announces that in an innovative endeavor,\n \n \n Voyageur and Rain Cage Carbon Inc.\n \n \n (\"Rain Cage\")\n \n \n are following\nup on the first commercial creation of a\n \n \n V@C\n \n \n 60\n \n \n endohedral fullerene (Vanadium atom inside\na\n \n \n C\n \n \n 60\n \n \n molecule). Rain\nCage is now embarking on the next phase of radiology drug development,\nby utilizing their cutting-edge technology.  Rain Cage will begin\ntesting to create on a commercial scale, the encapsulation of\ngadolinium, bismuth, and iodine within endohedral fullerenes. The\npioneering work, set to begin later this month, with the objective to\ndevelop a process to create\n \n \n Gd@C\n \n \n 60\n \n \n , Bi@C\n \n \n 60\n \n \n , and I@C\n \n \n 60\n \n \n endohedral\nfullerenes, targeting the development of highly advanced radiology\ncontrast agents for Magnetic Resonance Imaging (MRI) and CT scans.\nThese novel compounds, known for their rarity and complex synthesis,\nhold the promise of transforming medical imaging by significantly\nenhancing the precision and clarity of radiological scans.\n \n \n \n \n \"We are thrilled to be at the\nforefront of this groundbreaking initiative that marries cutting-edge\nnanotechnology with pharmaceutical innovation. Our collaboration with\nRain Cage in my view marks a pivotal moment in medical science, where\nthe development of endohedral fullerenes promises not just\nadvancements in radiology, but a paradigm shift in how we approach\ndiagnostic imaging. I believe this is just the beginning of a\ntransformative journey towards revolutionizing healthcare solutions\nfor the benefit of patients worldwide,\"\n \n \n stated Brent Willis, CEO of Voyageur.\n \n \n \n \n Endohedral fullerenes are a class of fullerenes that\nenclose an additional atom, ion, or cluster within their inner sphere,\nexhibiting superior physical and electronic characteristics compared\nto regular fullerenes. In the context of radiology...